Another genome-wide DNA methylation analysis in nonalcoholic steatohepatitis-related hepatocellular carcinomas found both hypomethylation of UBE2C promoters and UBE2C upregulation in hepatocellular carcinomas [29]. Here, UBE2C is linked to metabolic dysfunction-associated steatohepatitis.